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1 Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany, 2 Singapore Immunology Network (SIgN), IMMUNOS, Singapore, Singapore
Abstract
Background: Phenotype and function of regulatory T cells (Treg) largely depend on the presence of the transcription factor
FOXP3. In contrast to mice, human Treg cells express isoforms of this protein. Besides the full length version (FOXP3fl), an
isoform lacking the exon 2 (FOXP3D2) is co-expressed in comparable amounts. Recently, a third splice variant has been
described that in addition to exon 2 also misses exon 7 (FOXP3D2D7). Exon 7 encodes for a leucine zipper motif commonly
used as structural dimerization element. Mutations in exon 7 have been linked to IPEX, a severe autoimmune disease
suggested to be caused by impaired dimerization of the FOXP3 protein.
Principal Findings: This study shows that the lack of exon 7 does not affect (homo-) dimerization. Moreover, the interaction
of FOXP3D2D7 to RUNX1, NFAT and NF-kB appeared to be unchanged in co-immunoprecipitation experiments and reporter
gene assays, when compared to FOXP3fl and FOXP3D2. Nevertheless, retroviral transduction with FOXP3D2D7 failed to
induce the typical Treg-associated phenotype. The expression of FOXP3-induced surface molecules such as CD25 and CTLA-
4 were not enhanced in FOXP3D2D7 transduced CD4+ T cells, which also failed to exhibit any suppressive capacity. Notably,
however, co-expression of FOXP3fl with FOXP3D2D7 resulted in a reduction of CD25 expression by a dominant negative
effect.
Conclusions: The leucine zipper of FOXP3 does not mediate dimerization or interaction with NFAT, NF-kB and RUNX1, but is
indispensable for the characteristic phenotype and function in Treg cells. FOXP3D2D7 could play a role in regulating the
function of the other FOXP3 isoforms and may be involved in cancer pathogenesis, as it is overexpressed by certain
malignant cells.
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Introduction
Peripheral tolerance is maintained by various suppressor cells.
One important subset of these cells are regulatory CD4+ T cells
(Treg). They differ from ‘conventional’ effector CD4+ T cells in
the constitutive expression of the IL-2 receptor a-chain (CD25)
and other surface markers such as cytotoxic T lymphocyte-
associated antigen 4 (CTLA-4), glucocorticoid-induced TNFR
(GITR) and CD39 [1–4]. To date the most specific marker is the
forkhead box/winged helix transcription factor FOXP3 [5].
FOXP3 largely controls the development into Treg cells. Loss of
function due to mutations or complete absence of the transcription
factor leads to lethal autoimmune diseases in scurfy mice [6] and
the often fatal ‘immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome’ (IPEX) in humans [7].
Retroviral transduction of CD4+ T cells by FOXP3 is sufficient
to induce a Treg phenotype and the capacity to suppress
lymphoproliferation [5,8]. The human protein comprises 431
amino acids (aa). It contains a repressor domain (aa 67–132), a
zinc finger (aa 199–222), a leucine zipper motif (aa 239–260) and a
conserved DNA binding forkhead domain (FKH) at the C-
terminus (aa 335–418). FOXP3 acts as a functional repressor of
NFAT- and NF-kB-mediated gene transcription [9] and crystal
structure analysis for the homologue FOXP2 suggests that C-
terminal DNA-binding is associated with NFAT [10].
In contrast to mice, human Treg cells always display expression
of two FOXP3 isoforms. Both are expressed at similar levels of
which one representing the full length isoform (FOXP3fl), while
the other isoform lacks exon 2 (FOXP3D2) [11]. Exon 2 (aa 72–
106) associates and represses the function of retinoic acid-related
orphan receptors a and ct (RORa, RORct) [12,13]. As a
consequence the suppression of RORct-induced Th17 induction is
evident only with FOXP3fl [13,14], most other functions,
however, are either redundant or seem to have an additive impact
[15]. While both FOXP3fl and FOXP3D2 contribute to the
phenotype of human Treg cells, the genes affected by the two
isoforms seem to overlap only partly.
Recently, a third isoform has been identified lacking in addition
to exon 2 also exon 7 [16]. Exon 7 encodes for a leucine zipper
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6104
motif (aa 239–260; VX6LX6LX6L). The region was thought to be
indispensable for FOXP3 function, since the analysis of different
IPEX patients unveiled a concentration of fatal FOXP3 mutations
in the FKH and the leucine zipper region [17]. Leucine zippers
are a common dimerization element [18] and IPEX mutations
lacking either a lysine residue at position 250 or a glutamic acid
residue at position 251 in fact fail to dimerize during immuno-
precipitations [19,20]. Moreover, the region is also located
proximal to another important binding site. The Runt-related
transcription factor 1 (RUNX1) is reported to target a region c-
terminal to the leucine zipper, which seems to be crucial for the
induction of CD25 and the suppression of IL-2 [21].
In this study, we show that, despite the absence of the leucine
zipper, FOXP3D2D7 is still able to dimerize with all FOXP3
isoforms. Moreover, NFAT- and NF-kB-mediated transcription as
well as direct binding to RUNX1 are not affected by the absence
of exon 7. In contrast to FOXP3fl and FOXP3D2, FOXP3D2D7
fails to induce the expression of CD25 and CTLA-4 and does not
mediate suppressive capacity into transduced CD4+CD252 T
cells. As FOXP3D2D7 is able to inhibit the FOXP3fl- or
FOXP3D2-induced expression in a dominant negative fashion, it
may therefore have a regulatory impact on the function of the
other two isoforms.
Results
Expression and sub-cellular distribution of FOXP3
isoforms
Human Treg cells express constitutively high levels of the two
FOXP3 isoforms FOXP3fl and FOXP3D2 [5,22]. We generated
cDNA transcripts of purified Treg cells and identified in addition
to these two isoforms a splice variant that lacks exon 2 and also
exon 7. The latter was previously described as FOXP3D2D7 [16].
To test whether all FOXP3 isoforms can be expressed by
mammalian cells, HEK293T cells were transfected with
pcDNA3.1+ constructs, encoding for FOXP3fl, FOXP3D2 or
FOXP3D2D7. Western blot analysis of transfected cells showed
that all isoforms can be generated by the cell, migrating during
SDS-PAGE with an apparent molecular weight of 58kDa, 54kDa
and 50kDa, respectively (Fig. 1A). Fusion proteins linked N-
terminally to GFP further revealed that all three isoforms are
effectively translocated into the nucleus (Fig. 1B). Analysis by
fluorescence microscopy of HEK293T cells transfected with these
constructs showed bright staining of the nucleus, while GFP-
FOXP3DFKH, a truncated version lacking the DNA binding
domain is retained in the cytoplasm [23].
Western blot analysis of human Treg cells seems to reveal a faint
band presumably representing the FOXP3D2D7 isoform (Fig. 2A).
However, the experiment did not reveal a clear result regarding
the relative amount of FOXP3D2D7 as at higher lysate
concentrations the view was obstructed by the much broader
band of FOXP3D2 migrating slightly above FOXP3D2D7. To
determine the relative frequency of the three isoforms in human
PBMC we therefore performed also an RT-PCR analysis of
primary CD4+CD25+ T cells freshly isolated from healthy donors.
Primer pairs spanning from exon 1 to exon 2 (FOXP3fl), from
exon 1 to exon 3 (FOXP3D2) and from exon 6 to exon 8
(FOXP3D7) were used to analyse the amount of transcript for each
isoform. By comparing 5 different donors a similar pattern for the
relative ratios of FOXP3 splice variants was obtained (Fig. 2B). In
line with previous reports the dominant isoforms were FOXP3fl
and FOXP3D2. The amounts were comparable although, at least
on the transcriptional level, FOXP3D2 always exceeded FOXP3fl
2–3 times. In comparison, FOXP3D2D7 is much less frequent.
15–70 times less transcripts were detected compared to FOXP3fl.
In contrast to the isoforms of genes such as CD45 [24] the ratio
was apparently unaffected from the activation status of the cells.
Stimulation of Treg cells either with a-CD3 antibodies or with
PMA/Ionomycin did not change the ratio between isoforms (data
not shown).
Dimerization of FOXP3 is independent of exon 7
Since exon 7 encodes for a leucine zipper, it has been suggested
that this particular region is necessary for protein-protein-
interactions required for homodimerization [19]. To determine
the influence of the leucine zipper we, therefore, investigated the
ability of the natural isoforms to form complexes with
FOXP3D2D7. FLAG-tagged FOXP3fl was co-transfected with
FOXP3fl, FOXP3D2 or FOXP3D2D7 in HEK293T cells, and
dimeric FOXP3 complexes were isolated by immunoprecipitation
with a-FLAG agarose. Western blot analysis confirmed that
FLAG-FOXP3fl binds FOXP3fl, but also revealed that FOXP3D2
and, surprisingly, also the leucine zipper deficient FOXP3D2D7
isoform are able to bind FOXP3fl (Fig. 3A). Likewise, in a reversed
experiment, also FLAG-tagged FOXP3D2D7 was able to pull
down FOXP3D2 and FOXP3D2D7 (Fig. 3B). Similar results were
Figure 1. Ektopic expression of FOXP3 isoforms. (A) HEK293T
cells were transfected with plasmids encoding for FOXP3fl, FOXP3D2
and FOXP3D2D7 isoforms. Protein levels of splice variants were
analyzed by Western blots using isoform-non specific a-FOXP3 antibody
eBio7979. FOXP3 protein detection shown is representative for three
independent experiments. (B) HEK293T cells were transfected with
plasmids encoding for N-terminal GFP fusion proteins of FOXP3fl,
FOXP3D2, FOXP3D2D7 and FOXP3DFKH. GFP-FOXP3, GFP-FOXP3D2
and GFP-FOXP3D2D7 were translocated into the nucleus, whereas GFP-
FOXP3DFKH remained in the cytoplasm. Distribution of GFP-FOXP3
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also obtained when the precipitation was carried out with the
isoform-specific antibody clone FJK-16s (data not shown). Both
exon 2 and exon 7 were apparently not required for dimerization.
Thus, at least for homodimerization of FOXP3 the leucine zipper
is apparently not required.
FOXP3D2D7 represses NFAT- and NF-kB-mediated gene
transcription and binds RUNX1
For mouse, in vitro studies showed that NFAT- and NF-kB-
mediated gene transcription is repressed in the presence of Foxp3.
The effect is not observed with the mutant scurfy Foxp3 or
truncated Foxp3DFKH [9,22]. The reporter gene assays shown
here revealed that also the human FOXP3 isoforms are functional
repressors (Fig. 4A, B). This applied not only for FOXP3fl and
FOXP3D2 but, most notably, also for FOXP3D2D7. Indepen-
dently of the presence of exon 2 and exon 7, all isoforms reduced
NFAT-mediated gene transcription to a very similar extent
(,50%), (Fig. 4A). In line with this result, also NF-kB-mediated
transcription was inhibited (Fig. 4B). Co-transfection with
FOXP3fl lowered luciferase transcription levels to 31%, while
FOXP3D2 and FOXP3D2D7 even decreased the levels to 9 and
16%, respectively.
Another transcription factor known to interact with FOXP3 is
RUNX1 [21]. It was recently reported that the physical
interaction is apparently indispensable to assemble the active
FOXP3-transcription complex [21]. Co-immunoprecipitation
experiments revealed that both FOXP3 and FOXP3D2 are able
Figure 2. Expression of FOXP3fl, FOXP3D2 and FOXP3D2D7 in human Treg cells. (A) Protein expression levels of FOXP3 isoforms in human
Treg cells. CD25+CD4+ T cells were isolated from PBMC by MACS using a-CD25 Treg isolation kit. FOXP3-specific eBio7979 antibody was used after
Western blotting. The number of CD25+ cells loaded per lane is indicated. (B) RT-PCR analysis of human CD4+CD25+ cells. Relative transcription levels
of FOXP3 isoforms in five healthy donors were investigated.
doi:10.1371/journal.pone.0006104.g002
Function of FOXP3D2D7
PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6104
to bind the transcription factor. Moreover, although the RUNX1
binding region of FOXP3 is in close proximity to the leucine
zipper, also FOXP3D2D7 was still capable to bind RUNX1
(Fig. 4C). Thus, the presence of exon 2 or exon 7 is not required
for binding to RUNX1 or the interaction with NFAT or NF-kB.
FOXP3D2D7 gene transfer does not confer suppressive
capacity
Previous studies indicate that transduction of FOXP3fl and
FOXP3D2 is sufficient to render human CD4+CD252 cells into
Treg-like suppressor cells [8,15]. To investigate whether also
FOXP3D2D7 confers suppression we transduced freshly isolated
CD4+CD252 T cells with the three human FOXP3 isoforms.
Gene transfer was performed first with CD252 mouse T cells to
prevent interference with endogenous FOXP3 expression known
to by induced in human T cells upon activation [11,25]. The effect
of human FOXP3 was compared to murine Foxp3 or the ‘empty’
retroviral control vector. Suppression by transduced cells was
determined by FACS after co-culture with CFSE-labelled
CD4+CD252 responder cells. As expected, proliferation of
Figure 3. Dimerization of FOXP3fl, FOXP3D2 and FOXP3D2D7 with FOXP3D2D7. (A) HEK293T cells were co-transfected with FLAG-tagged
FOXP3fl (left panel) or empty vector (right panel) and either control vector, FOXP3fl, FOXP3D2 or FOXP3D2D7. Co-immunoprecipitation experiments
(IP) were performed with a-FLAG agarose and complexes were analyzed in immunoblots (IB) with FOXP3-specific antibody eBio7979 (upper panels).
Expression of non-FLAG-tagged constructs was confirmed by immunoblotting of total cell lysates (lower panels). Co-immunoprecipitation shown is
representative for three independent experiments. (B) HEK293T cells were co-transfected with FLAG-tagged FOXP3D2D7 and either control vector,
FOXP3D2 or FOXP3D2D7. IP was performed with a-FLAG agarose and complexes were analyzed in IB as described above. Co-immunoprecipitation
shown is representative for three independent experiments.
doi:10.1371/journal.pone.0006104.g003
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responder cells was completely blocked in the presence of CD25+
Treg cells freshly isolated from mice or with cells transduced with
mouse Foxp3 (Fig. 5A). Suppression was also observed with mouse
cells transduced with human FOXP3fl and FOXP3D2. In
contrast, proliferation of responder cells in the presence of
FOXP3D2D7 transduced cells was completely unaffected. The
discrepancy was particularly evident when titrating the FOXP3-
transduced T cells, suggesting that FOXP3D2D7 apparently fails
to transfer any detectable suppressor function (Fig. 5B).
FOXP3D2D7 fails to induce Treg-specific phenotype
Since FOXP3D2D7 is apparently not able to transfer suppres-
sive capacity, we investigated whether at least surface markers
associated with Treg cells were induced. For this, mouse
CD4+CD252 T cells were transduced with retroviral FOXP3
constructs in which their expression was linked to GFP (FOXP3-
IRES-GFP). After 4 days post-transduction the cells were analysed
by FACS for GFP-, CD252 and CTLA-4-expression. Transduc-
tion with FOXP3fl and FOXP3D2 as well as murine Foxp3
induced the expression of CD25. The increase was proportional to
the amount of Foxp3, indicated by the GFP fluorescence (Fig. 6A).
In contrast, cells transduced with FOXP3D2D7 or control vector
did not show any upregulation. The quantification of the
induction revealed that both human FOXP3fl and FOXP3D2
induced CD25 expression to a level of approximately 60%
compared to murine Foxp3, while no enhancement was observed
with FOXP3D2D7 (Fig. 6B). Similar results were also observed
with CTLA-4 (Fig. 6C). Compared to murine Foxp3, transduction
with human FOXP3fl and FOXP3D2 provoked an increase of
CTLA-4 expression to 40 and 30%, respectively, FOXP3D2D7
showed no induction of CTLA-4.
The same effect was observed also when human CD4+CD252
T cells were transduced with the construct. In line with previous
reports [8,15], the overexpression of both FOXP3fl and
FOXP3D2 enhanced the expression of CD25 (Fig. 6D). In
contrast, FOXP3D2D7 failed to induce any significant increase
of the marker although western blot analysis confirmed the
expression of the transduced FOXP3 isoform in addition to lower
amounts of activation-induced endogenous FOXP3fl and
FOXP3D2 (data not shown).
FOXP3D2D7 exhibits a dominant negative effect on
FOXP3-induced CD25 expression
Despite the lack of function, FOXP3D2D7 was able to recruit
transcription factors such as NF-kB, NFAT or RUNX1 (see Fig. 4).
By competing for these factors with the other two isoforms, it may
therefore act as dominant negative inhibitor. To address this
Figure 4. All FOXP3 isoforms interact with NFAT, NF-kB and
RUNX1. (A) FOXP3 isoforms repressed NFAT-mediated transcription of
luciferase in reporter assays. NIH3T3 cells were co-transfected with
either control vector, FOXP3fl, FOXP3D2 or FOXP3D2D7 and NFAT
luciferase reporter plasmid. Transcription was normalized to Renilla
luciferase activity; the average induction in absence of FOXP3
expression was set 100%. Reporter gene assay shown is representative
for three independent experiments. Error bars represent SD; statistical
analysis was performed with 2-tailed unpaired student’s t-test. (B)
FOXP3 isoforms repressed NF-kB-mediated transcription of luciferase.
Experiments were carried out as above except that a NF-kB luciferase
reporter plasmid was used. Reporter gene assay shown is representative
for three independent experiments. Error bars represent SD; statistical
analysis was performed with 2-tailed unpaired student’s t-test. (C)
FOXP3 isoforms bind RUNX1 in co-immunoprecipitation experiments.
HEK293T cells were co-transfected with FLAG-tagged RUNX1 and either
control vector, FOXP3fl, FOXP3D2 or FOXP3D2D7. Co-immunoprecip-
itation experiments (IP) were performed with a-FLAG agarose and
complexes were analyzed in immunoblots (IB) with the FOXP3-specific
antibody eBio7979 (upper panels). Expression of non-FLAG-tagged
constructs was confirmed by immunoblotting of total cell lysates (lower
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Figure 5. Suppression of CFSE labelled responder cells by FOXP3-transduced T cells. (A) Suppressive capacity of FOXP3 isoforms. Freshly
isolated murine CD4+CD252 cells were labelled with carboxy-fluorescein diacetate succinimidylester (CFSE). Lymphoproliferation was detected in co-
culture experiments with FACS-sorted FOXP3-transduced CD4+ cells or freshly isolated CD4+CD25+ regulatory mouse T cells in the presence of plate
bound a-CD3 and irradiated APC. Ratio of suppressor cells to responder cells was 1:3. CFSE dilutions were analysed by flow cytometry after 4 days,
gating on live CD4+ T cells. Proliferation was suppressed by freshly isolated CD4+CD25+ regulatory T cells (Treg) and CD4+CD252 T cells transduced
with murine Foxp3 (mFoxp3), with human FOXP3fl or FOXP3D2 but not with T cells transduced with empty control vector (Control) or with
FOXP3D2D7. Suppression assay shown is representative for three independent experiments. (B) Titration of FOXP3-transduced suppressor T cells
Function of FOXP3D2D7
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question, murine CD4+CD252 T cells were co-transduced with
FOXP3fl and FOXP3D2D7. To identify cells expressing both
isoforms retroviral IRES-constructs were used that encoded for
two different fluorescent proteins (FOXP3fl-IRES-CFP,
FOXP3D2D7-IRES-GFP or the ‘empty’ IRES-GFP control
vector). When comparing FOXP3fl-IRES-CFP/IRES-GFP trans-
duced cells with FOXP3fl-IRES-CFP/FOXP3D2D7-IRES-GFP
transduced cells, we observed indeed a significant inhibition of the
FOXP3-induced CD25 expression (Fig. 7). In all cases, a reduction
in the increase of CD25 related MFI was observed. Thus, at least
in principle FOXP3D2D7 can exhibit a dominant negative effect
on the functionally active full-length form of human FOXP3.
Discussion
In this study we showed that in addition to the two dominant
isoforms FOXP3fl and FOXP3D2 a third splice variant,
FOXP3D2D7, exists, which still binds to transcription factors,
such as NFAT, NF-kB and RUNX1. While it lacks apparently its
suppressive functions, it is able to inhibit FOXP3fl in a dominant
negative manner. The effect is caused by the loss of exon 7,
encoding for a typical leucine zipper domain usually used for
homo-/heterodimerization.
Alternative splicing is a mechanism commonly used by
eukaryotes to increase the functional variety of proteins by exon
creation and/or loss [26]. It is estimated that about 40–60% of
human genes are alternatively spliced. In the case of FOXP3 the
loss of exon 2 eliminates some of its repressor function, as it
abrogates the interaction with RORct, the transcription factor
driving the differentiation towards Th17 [14]. In addition to this,
FOXP3D2D7 also lacks the leucine zipper domain in exon 7,
which has been thought to be particularly crucial for the
homodimerization of FOXP3. The latter assumption was based
on the impaired dimerization reported for IPEX mutations
DK250 and DE251 targeting this region [19,20]. Surprisingly,
however, the complete loss of this region in FOXP3D2D7 did
clearly not impair homodimerization with itself or any of the other
FOXP3 isoforms. Also the homologue region in the N-myc protein
was initially thought to be required for homodimerization [27].
Recent findings showed instead that the N-myc leucine zipper
mediates exclusively heterodimerization with other binding
partners [28,29]. In analogy, also exon 7 may therefore primarily
mediate interactions with leucine zipper proteins other than
FOXP3.
In contrast to the IPEX-linked single amino acid deletions
DK250 and DE251 [19,20], the complete absence of exon 7 did
not affect NFAT-mediated transcriptional repression. In this
respect, the single amino acid deletions seem to have a more
dramatic effect on the overall structure of the protein than the loss
of the domain. Moreover, also the interaction with NF-kB was
apparently not disturbed by the missing exon. This, however, may
depend on the experimental system, since others have reported an
isoform-specific effect in transfected Jurkat cells [30]. Recent data
obtained by crystal structure analysis and co-immunoprecipitation
experiments mapped the binding site of the NFAT RelA domain
to the forkhead domain of FOXP3 [10], whereas RUNX1 targets
a region starting at the c-terminus of exon 7 [21]. The phenotype
induced by a FOXP3 mutant failing to bind RUNX1 is
characterized by a loss of suppression and abrogation of CD25
induction [21]. Although this would have matched the phenotype
induced by FOXP3D2D7, co-immunoprecipitation experiments
clearly showed that RUNX1 is still able to bind.
Smith et al. reported that FOXP3D2D7 inhibits IL-2 release
and CD69 upregulation in T cells cotransfected with a chimeric
CD28/TCRf receptor [16]. In our system, however, FOXP3
transduction had no influence on CD69 expression (data not
shown). In contrast to FOXP3fl and FOXP3D2, FOXP3D2D7
does not increase CD25 and CTLA-4 expression. Moreover,
FOXP3D2D7 expressing T cells are not able to inhibit
lymphoproliferation. Thus, while FOXP3D2D7 is able to recruit
transcription factors, it is apparently functionally inactive with
regard to the suppressor functions commonly linked to FOXP3.
Notably, co-expression of FOXP3D2D7 and FOXP3fl resulted in
a reduction of FOXP3-induced CD25 expression but no
FOXP3D2D7-mediated downregulation of CD25 was observed
after exogenous overexpression in freshly isolated CD4+CD25+
human Treg cells (data not shown). Although FOXP3D2D7
clearly exhibits a dominant negative effect, at this point it is not
clear yet if it is caused solely by the competition for transcription
factors or also by the occupation of DNA binding sites. Also still
unclear is whether FOXP3D2D7 lost any ability to induce a Treg-
like expression pattern or if some direct inducer/repressor function
is conserved.
The crucial question relates to the physiological role of the
FOXP3D2D7 splice variant. In natural Treg, FOXP3D2D7 is
present at rather low copy numbers. The dominant negative effect
observed in vitro after ectopic expression is therefore unlikely to
have any significant impact in these cells. Others have shown,
however, that FOXP3D2D7 is overexpressed by certain malignant
cells. Sézary Syndrome is an aggressive variant of cutaneous T cell
lymphoma. A recent study suggests that in most cases the
transformed T cells express FOXP3, but only FOXP3D2 and,
even more abundantly, FOXP3D2D7 [30]. Moreover, FOXP3
also plays a role in breast cancer, as FOXP3fl acts as repressor of
Her-2 [31]. Future studies have to establish, however, whether the
isoform actually plays a role in cancer pathogenesis.
Materials and Methods
Cell purification
Balb/c mice purchased from Charles River Laboratories were
housed in the animal facility of the Max Delbrück Center for
Molecular Medicine and handled in accordance with the
institutional guidelines. Lymphocyte populations were isolated
from spleen and lymph node by using ‘mouse CD4+CD25+
Regulatory T cell Isolation Kit’ (Miltenyi) according to manufac-
turer’s instructions. Human PBMCs from healthy volunteers were
isolated by Ficoll centrifugation (GE Healthcare); Treg cells were
isolated using ‘human CD4+CD25+ Regulatory T cell Isolation
Kit’ (Miltenyi) according to manufacturer’s instructions. Purity of
magnetic bead isolated cell populations was always greater than
92%. All animal experiments were approved by the Landesamt für
Arbeitsschutz, Gesundheitsschutz und Technische Sicherheit
(Berlin, Germany). Approval for use of human PBMCs was
obtained from the MDC institutional review boards for these
studies. Informed consent was obtained in accordance with the
Declaration of Helsinki.
(Tsupp) and CFSE labelled responder T cells (Tresp). Experiment was carried out as described above except that T cells transduced with FOXP3fl,
FOXP3D2 or FOXP3D2D7 were titrated to indicated ratios. The experiment was carried out in triplicates; error bars represent the SD. Inhibition is
expressed as relative suppression in reference to the proliferation of T cells transduced with the empty vector.
doi:10.1371/journal.pone.0006104.g005
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Figure 6. Absence of exon 7 prevents the induction of Treg associated surface markers. (A) Mouse CD4+CD252 T cells were transduced
with retroviral vectors encoding for FOXP3-IRES-GFP. An increase of CD25 expression in GFP+ cells was observed in T cells transduced with murine
Foxp3 (mFoxp3), human FOXP3fl and FOXP3D2, but not with empty vector (Control) or with FOXP3D2D7. Data shown is representative for six
independent experiments. (B) Induction of CD25 expression was quantified by the relative increase of the mean fluorescence intensity (MFI) from
GFPlow to GFPhigh transduced cells. The increase is shown in reference to the increase by mFoxp3. Data represent the mean of six individual
experiments. Error bars represent SD; significance was determined by using the unpaired student’s t-test. (C) Induction of CTLA-4 expression. Relative
Function of FOXP3D2D7
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Cell culture
T cells were cultured in RPMI/10% FCS, supplemented with,
2 mM L-Glutamine, 1 mM non-essential amino acids, 10 mM
HEPES, 50 mM b-Mercaptoethanol (all from Invitrogen),
100 IU/ml Penicillin/100 mg/ml Streptomycin (Cambrex) and
1 mM Pyruvate (Roth). HEK293T cells and NIH3T3 cells were
cultured in DMEM/5% FCS medium, supplemented with 2 mM
L-Glutamine, 1 mM non-essential amino acids, 50 mM b-
Mercaptoethanol (all from Invitrogen) and 100 IU/ml Penicil-
lin/100 mg/ml Streptomycin (Cambrex). Retroviral packaging
cells, Platinum E (PlatE) cells [32], were cultured in DMEM/5%
FCS and selected packaging-competent with Puromycin (1 mg/ml)
and Blasticidin (10 mg/ml) and cultured at 32uC to maximize
ecotropic virus titer.
RT-PCR
mRNA was isolated with Trizol (Invitrogen), cDNA derived
from human Treg cells was generated by using poly-dT primer
and RT-Superscript II (Invitrogen). FOXP3 isoforms were
obtained from this cDNA using the primer pair: 59-ACGC-
TACTCGAGGCCACCATGCCCAACCCCAGGCCTG-39
(sense) and 59- TGCGAGGAATTCTCAGGGGCCAGGTG-
TAGGG-39 (antisense). RT-PCR was carried out with exon
overlapping primer pairs: 59-CAGCTGCAGCTGCCCA-
CACTG-39 (sense) and 59-GCCTTGAGGGAGAAGACC-39
(antisense) for FOXP3fl, 59-CAGCTGCAGCTCT-
CAACGGTG-39 (sense) and 59-GCCTTGAGGGAGAAGACC-
39 (antisense) for FOXP3D2 and 59-GAGCAGCAGGCAT-
CATCCG-39 (sense) and 59-CTGGGAATGTGCTGTTTCC-39
(antisense) for FOXP3D2D7. RT-PCR reactions were performed
using RealMasterMix (Eppendorf) according to the manual.
Cycling conditions were 2 min at 95uC, followed by 55 cycles of
15 sec 95uC, 45 sec 58uC and 30 sec 68uC, finally 1 min 95uC
and 1 min 55uC; at the end of the PCR specific amplification
products were confirmed by melting curves and 2% agarose gel
electrophoresis. FOXP3 expression was normalized to Hypox-
anthin-Guanin-Phosphoribosyltransferase (HPRT) and GAPDH
expression.
Constructs
FOXP3 isoforms were cloned into pcDNA3.1+ (Invitrogen) for
reporter gene assays, into pCMV-Tag2 (provided by S. Sakaguchi,
Kyoto University, Japan) for FLAG-tagged FOXP3 co-immuno-
precipitation experiments, and into retroviral MIGR1 vector
(provided by S. Sakaguchi, Kyoto University, Japan) containing an
internal ribosome entry site (IRES)-GFP. Replacement of GFP
with cyan fluorescence protein (CFP) into MIGR1 was performed
via NcoI/SalI cloning, using 59-ACGCTCCATGGGCCAC-
CATGGTGAGCAAGGGCGAG-39 (sense) and 59-
TGCGAGTCGACCTACTTGTACAGCTCGTCCATG-39 (an-
tisense) and pLP-ECFP-C1 (Clontech) as template. FLAG-tagged
RUNX1 co-immunoprecipitation experiments were carried out
expression was determined as described above. Data represent the mean of three individual experiments. Error bars represent SD; significance was
determined by using the unpaired student’s t-test. (D) Transduction of human CD4+CD252 T cells. The relative increase in expression is shown for
CD25. The experiment was carried out as described above except that the relative increase in shown in reference to human FOXP3fl. Data represent
the mean of four individual experiments. Error bars represent SD; significance was determined by using the unpaired student’s t-test.
doi:10.1371/journal.pone.0006104.g006
Figure 7. FOXP3D2D7 can act as dominant negative inhibitor of FOXP3fl. Mouse CD4+CD252 T cells were transduced with retroviral vector
pairs encoding for FOXP3fl-IRES-CFP / IRES-GFP or FOXP3fl-IRES-CFP / FOXP3D2D7-IRES-GFP. The relative increase in CD25 expression was measured
by determining the increase in mean fluorescence intensity (MFI) from GFP+ single transduced cells to GFP+CFP+ double transduced cells. The
FOXP3fl-induced CD25 expression was significantly lower in the presence of FOXP3D2D7. Data represent the mean of four individual experiments; p-
value was determined by using the paired student’s t-test.
doi:10.1371/journal.pone.0006104.g007
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with pCMV-RUNX1-Tag2 (provided by S. Sakaguchi, Kyoto
University, Japan). For translocation experiments FOXP3 iso-
forms and FOXP3DFKH (lacking C-terminal 104aa) were cloned
into pcDNA3.1+, followed by N-terminal fusion to GFP, using 59-
ACGCTGGGATCCGCCGCCACCATGGCCACAAC-
CATGGTGAGC-39 (sense) and 59-TGCGACGAATTCCTTG-
TACAGCTCGTCCATGCC-39 (antisense). Integrity of con-
structs was confirmed by sequencing.
Transfection and virus production
HEK293T cells (ATCC) were transfected by using Fugene
transfection reagent (Roche). Ecotropic virus was produced by
transfection of PlatE cells with MIGR1 constructs as described [5].
Amphotropic virus was produced in HEK293T cells after
transfection with MIGR1 constructs, pALF-10A1 and
pcDNA3.1MLVg/p as described [33].
Transduction
Retroviral gene transfer of primary murine CD4+ T cells were
performed according to previous reports [5]. Briefly, 26106 freshly
isolated MACS-isolated murine CD4+CD252 cells were incubat-
ed with 7 mg/ml plate bound a-CD3 (145.2C11, purified at the
MDC from cell supernatant), 16106 irradiated APCs and 100 IU/
ml IL-2 (Roche Diagnostics) in a 24-well plate over night. Spin-
infection was carried out on the following 2 days with filtered virus
supernatant, in the presence of 7 mg/ml Polybrene at 1800 rpm,
90 min, 32uC. 10 IU/ml IL-2 was supplemented on day 2 after
cell isolation. For transduction of human cells 26106 freshly
isolated human CD4+CD252 cells were incubated with 5 mg/ml
plate bound a-CD3 (OKT3, eBioscience) and 1 mg/ml a-CD28
(28.2, BD Biosciences) and 100 IU/ml IL-2 in a 24-well plate for
36 h. Spin infection was carried out as described [33]. Gene
expression patterns were measured at day 6 by flow cytometry.
Flow cytometry
Gene expression was quantified by antibody staining of mCD4
(GK1.5), mCD25 (PC61), hCD4 (RPA-T4) and hCD25 (M-A251)
(all antibodies from BD Biosciences). For intracellular a-CTLA-4
staining (UC10-4F10–11, BD Biosciences), cells were treated 6 h
with PMA (50 ng/ml), Ionomycin (1 mM) and Brefeldin A (2 mg/
ml, Sigma-Aldrich). Dead cells were excluded from analysis by life
gating using propidium iodide. FACS analysis was carried out on a
LSR II (BD Biosciences), cells were sorted on a FACSAria (BD
Biosciences). Data were analysed using FACSDiva software (BD
Biosciences). Induction of gene expression in FOXP3-IRES-GFP
transduced cells was performed by comparing MFI values of
GFPlow and GFPhigh expressing cells. In GFP/CFP double
transduction experiments to determine the dominant negative
effect of FOXP3D2D7, the increase in CD25 expression was
compared in response to IRES-GFP / FOXP3fl-IRES-CFP and
FOXP3D2D7-IRES-GFP / FOXP3fl-IRES-CFP.
Suppression assay
Freshly isolated murine CD4+CD252 cells were labelled with
2,5 mM CFSE (Invitrogen) and plated at 16105/well in 96-well
plates, stimulated with 3 mg/ml plate bound a-CD3 (145.2C11,
purified at the MDC) and 56104 CD4- cells as APC, irradiated at
30 Gy. Responder cells were co-cultured with FOXP3-transduced
CD4+ cells, sorted before based on the corresponding GFP or
CFP fluorescence, or with freshly isolated CD4+CD25+ regulatory
T cells. Proliferation was determined after 4 days by flow
cytometry by recording CFSE dilutions.
Reporter gene assay
Luciferase reporter assays were carried out with the following
constructs: pNFAT-TA-Luc (Clontech) and pNF-kB-Luc (Strata-
gene) (both provided by R. Baumgras, DRFZ, Germany).
Endotoxin was removed with TritonX-114 [34]. Endotoxin levels
were measured with limulus amebocyte lysate assay (QCL-1000,
Cambrex) according to manufacturer’s instructions. NIH3T3 cells
were transiently transfected with 1 mg total DNA using Lipofecta-
mine 2000 (Invitrogen). The ratio of transfected plasmids was: 1
part pRL-CMV (Promega), 10 parts indicated firefly luciferase
reporter gene construct and 50 parts indicated FOXP3 expression
construct. Cells were lysed after 48 h; samples were measured as
triplicates; variations in the transfection rate were compensated by
normalizing to the Renilla luciferase activity.
Western blotting and Immunoprecipitation
Protein interactions were detected by co-immunoprecipitation
as previously described [21]. Briefly, HEK293T cells were
transfected with pcDNA3.1+ constructs encoding for Flag-tagged
and non-tagged proteins. After 3 days cells were lysed in non-
denaturating buffer (150 mM NaCl; 50 mM Tris-HCl, pH: 7,5;
1% Nonidet P-40; 0,5% sodium deoxycholate) containing protease
inhibitor (Roche). Lysates were centrifuged (5 min, 13000 rpm)
and the supernatant was incubated 2 h at 4uC with a-FLAG M2
affinity gel (SigmaAldrich) while gently rocking. The beads were
centrifuged (30 sec, 1000 rpm) and washed 6 times with cold lysis
buffer. Samples were denatured by 95uC for 10 min and separated
on 10% SDS-PAGE. Proteins were transferred to Immobilon P
membrane (Millipore) using Transblot SD (Biorad) at 0,8 mA/
cm2 for 1 h. Membranes were blocked with 2,5% milk, and
incubated with isoform-non specific a-FOXP3 (e7979,
eBioscience), followed by washing and incubation with secondary
HRP-conjugated antibody (Dako). Protein bands were visualized
by ‘ECL Plus Western Blotting Detection Reagents’ (GE
Healthcare).
Statistics
Statistical analysis was performed with 2-tailed paired or
unpaired student’s t-test using Sigmaplot software (San Jose). P-
values less than 0,05 were considered statistically significant. All
error bars represent the standard deviation (SD).
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